HEATHER STAFFORD: Open Payments
NPI 1992143994 · FAYETTEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 17 payments from 6 companies in 2025. Trend: 2023 $565 · 2024 $298 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $77 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| ABBVIE INC. | 3 | $51 |
| Alkermes, Inc. | 1 | $23 |
Products named: INGREZZA, CAPLYTA, REXULTI, VRAYLAR, UZEDY, ARISTADA, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across TN — which companies pay providers there.
